Thomas Nitschke Kledal

5PUBLICATIONS
4CO-AUTHORS
Natural products and bioactive compoundsOrganic chemical synthesisCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 28, 2022
Publisher Correction: Reply to: How many SARS-CoV-2 "viroporins" are really ion channels?

Trine L Toft-Bertelsen, Mads Gravers Jeppesen, Asante Landbrug

|Aug 25, 2022
Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels?

Trine L Toft-Bertelsen, Mads Gravers Jeppesen, Asante Landbrug

|Dec 11, 2021
Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro.

Trine Lisberg Toft-Bertelsen, Mads Gravers Jeppesen, Eva Tzortzini

|Dec 02, 2021
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.

Trine Lisberg Toft-Bertelsen, Mads Gravers Jeppesen, Eva Tzortzini

|Aug 27, 2021
Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1.

Julius Maximilian Knerr, Thomas Nitschke Kledal, Mette Marie Rosenkilde

Pageof 1

Frequent Collaborators

5 joint publications

Mette Marie Rosenkilde

2 joint publications

Eva Tzortzini

2 joint publications

Stefan Becker

2 joint publications

Loren B Andreas